Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

flosequinoxan

Known as: 7-fluoro-1-methyl-3-methylsulfonyl-4-quinolone 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
AbstractDesign: A randomised, double-blind, prospective, placebo-controlled four-way study of the pharmacokinetics of single oral… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1997
1997
The forms of cytochrome P450 involved in the stereoselective S-oxidation of flosequinan [(+/-)-7-fluoro-1-methyl-3-methylsulfinyl… Expand
Is this relevant?
1997
1997
The forms of cytochrome P450 involved in the stereoselective S-oxidation of flosequinan [(6)-7-fluoro-1-methyl-3-methylsulfinyl4… Expand
  • figure 1
  • figure 2
  • table 1
  • table 3
  • figure 3
Is this relevant?
1996
1996
Objective: The pharmacokinetics of flosequinan were studied in a group of 18 patients with chronic cardiac failure. Results:After… Expand
  • table 1
  • table 2
Is this relevant?
1995
1995
In guinea-pig papillary muscles the positive inotropic effect of flosequinoxan (BTS) starting at 100 μmol/1 amounted to 287.6… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1994
1994
The pharmacokinetics of flosequinan and its active metabolite, flosequinoxan, were investigated following a single 100-mg oral… Expand
Is this relevant?
1994
1994
We wished to provide comparative information regarding the direct effects of flosequinan, a novel quinolone under development for… Expand
Is this relevant?